Nanologica AB (publ)

Headline then, we have delivered our products finally to customers, both to incident manufacturers and to customers in China who have paid. We have received an order for a silica-based product, a lab sieve, for 3.6 million SEK and we have strengthened the production team in Södertälje and also in the factory. Then, after the release of the period, we have announced a preferred emission. A little about figures then. 1.4 million is a little over in sales, especially columns, a little silica here at the end. Minus 70 million in turnover results, minus 75 result after tax and 10 million at the beginning of the period in the cash register. I would also like to comment on two slightly larger descriptions we do. We have one of 5 million that is a medical care project that we have put on pause and now also concluded. Vi har en nedskrivning på 10 miljoner som egentligen härhör sig från de problem vi har rapporterat om tidigare. Vi har haft ganska stora produktionsproblem. Jag har också berättat att vi har förstört en del material. Det är helt enkelt den typen av material som vi tar bort från balansräkningen. Det gör också att vi går in i 2024 med en väldigt fräsch balansräkning som vi är väldigt nöjda med. In terms of sales, very strong support from existing owners. Technical connection at about 40%. In addition, we actually have four owners who are with me in the warranty consortium and who would like to sell more shares. The external guarantors, there are four of them, are very good, I think. We have met them and they would like to have shares in the company. Totalt på 54,2 miljoner brutto då på 76,5 och det är teckningsperioden 28 februari till 13 mars. Själva det den har tecknat om jag haft möjlighet, min prorata är då 3 miljoner och det har jag tyvärr inte möjlighet att göra. Men det hade varit väldigt trevligt att vara med. Jag är ju stor ägare sedan tidigare och vill gärna förbli det. The money will be used for investment in production and sales. The idea is that we will start selling, get a stable cash flow and eventually get a positive cash flow. We have reported that the production is an ideal problem. The problems have solved themselves, and we are also starting to see the fruits of it. More specifically, we have had problems with two of our final steps, not in silica production, but after treatment. The step that we have had the most problems with has been the route to Lunda, where we have changed equipment. We have now run five times in the new equipment. Then we mean that it is starting to become stable, we can rely on it. The last step we have also had some problems with. We have also changed equipment where we have driven twice and it has gone well. Then we have driven a few more times before we feel that we are completely stable. A little bit in line with what we have done with the last step when we have driven five times. But at the same time, we get products out. We can sell products. We have some products on the shelf. It is very, very good and that is what the customers are asking for. There is a big difference compared to when we were only a quarter ago. A huge difference. A little bit about customers then. We have focused mainly on Asia, India and China, where we have orders that have been delivered, we have had a lot of customer visits, a lot of evaluation that is ongoing. We have been waiting with, especially in the USA and Europe, even though we have had a little activity there, it has to do with the fact that we have not had products on the shelves and it is something that we feel that we want to have in the back when the view turns west. So we have started that now from the change of year and it feels super exciting to follow that development as well. Enlabsiv is a non-silica-based product. It's this order that we have for 3.5 million SEK, which we will deliver very soon. It's only a few weeks away. It is manufactured by a partner, a little like we manufacture silica, although it is not silica, it is another type of media. It has been developed for a long time together with a customer and now they are in production. They have a very high need for this type of product and they want to switch to our product. So we think that this will go beyond a production contract pretty soon. Exactly when is hard to say, but that it will be a comprehensive contract when it does happen, it is without a doubt. So it's a super exciting development that we might not have thought would go this fast. But it's fun to do it. And it's the same type of model, the same type of price, the same type of technology, but a different product than what we used earlier. In the future, there has been a lot of focus on production. We have had huge problems since we started in 2019 and forward. We thought it would go faster. It hasn't done that. It has taken longer than we had hoped. But now we are starting to deliver products. The steps that have been taken, one of them is stable, the other is about to become stable, but over time we get products out, the products we start to sell, and that's something completely different when you can start to deliver the product to customers. I'm not going to say it's magic, it feels like magic because it's taken so long, but it's not magic, it's the fruit of very, very hard work by the team, both in Södertälje and in i vår produktionsanläggning i England. Det är jättekul att äntligen få komma hit. Det avslutar min kommentar kring vårt bokflyttskommuniqué för helåret 2023. Tack för att ni lyssnade. Andreas Bhagwan heter jag och det här är Over and Out från Nanodotika i Södertälje.